Complete

How a genetic parasite contributes to cancer development

Cancer types:

General cancer research

Project period:

Research institute:

The Rockefeller University

Award amount:

£181,175

Location:

USA

Researcher Dr John LaCava

Dr John LaCava aims to work out how a genetic "hitchhiker" helps to promote and sustain the growth of cancers. 

Meet the scientist

John is a research professor at The Rockefeller University where he leads a team specialising in understanding the molecules within our cells that make them work. He is also the founder of B13LOGY LLC a service provider for studying how proteins in our cells interact with each other. 

The science

Our DNA is a history book, telling the story of who we are and how we arrived here over hundreds of millions of years of evolution. Our genomes contain many ancient remnants of the past, including sections of genetic code known as “L1 retrotransposons” that have recently become of great interest to cancer researchers. These ancient bits of DNA are genetic parasites, hitching a ride on our DNA and able to “copy and paste” themselves throughout our genome. 

L1 retrotransposons play a role in cancer but little is known about how they act to promote and maintain cancer. In over 50 per cent of cases, the cancer genome contains more L1 retrotransposons then DNA from healthy cells, and the more the cancer genome contains, the more severe the disease seems to be. 

The piece of genetic code contained within L1 retrotransposons carry the instructions that cells use to build two different proteins. And it’s only by interacting with other proteins in the cell that these proteins can make cancer cells grow and divide. Dr John LaCava and his team based at the Rockefeller University in New York, USA, are trying to unravel the network of interactions between these proteins to get a grasp of how L1 retrotransposons drive cancer. It is these discoveries that could open up new avenues for improving diagnosis and treatment of cancer. 

Related projects

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page